Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence

AJR Am J Roentgenol. 2003 Jun;180(6):1601-4. doi: 10.2214/ajr.180.6.1801601.

Abstract

Objective: The aim of this study was to investigate the CT findings and prevalence of hepatic subcapsular steatosis in patients undergoing peritoneal dialysis with intraperitoneal insulin delivery.

Conclusion: Hepatic subcapsular steatosis appeared as subcapsular nodules and often rindlike areas of low attenuation in seven (18%) of 39 patients who received intraperitoneal insulin with their peritoneal dialysate. Cessation of intraperitoneal insulin therapy led to reversal of the steatosis in three patients.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Fat Necrosis / diagnostic imaging*
  • Fat Necrosis / epidemiology
  • Fat Necrosis / etiology*
  • Fatty Liver / diagnostic imaging*
  • Fatty Liver / epidemiology
  • Fatty Liver / etiology*
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / adverse effects*
  • Infusions, Parenteral / adverse effects*
  • Insulin / administration & dosage*
  • Insulin / adverse effects*
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / diagnostic imaging*
  • Kidney Failure, Chronic / therapy
  • Male
  • Middle Aged
  • Peritoneal Dialysis / adverse effects
  • Prevalence
  • Reproducibility of Results
  • Tomography, X-Ray Computed*

Substances

  • Hypoglycemic Agents
  • Insulin